A method for red blood cell biotinylation in a closed system.

Tracking red blood cell survival is important for evaluating transfusion outcomes and new blood products. Biotin labeling has been used to distinguish donor RBCs in recipients. However, existing methods lack standardization and validation. No prior work had resolved the issue of sterile, reproducible biotinylation in clinical settings. Researchers needed a reliable way to label RBCs without compromising their function. This gap motivated the development of a closed-system method. Prior research has shown that biotin can label RBCs effectively. But no prior work had produced a validated, fast, and compliant process. This study aimed to address that limitation.

The study aimed to develop a standardized method for biotin labeling of red blood cell concentrates. The goal was to ensure sterility and compliance with Good Practice Guidelines. Researchers wanted to test two biotinylation reagent concentrations in a closed system. They also aimed to assess the impact of labeling on RBC function. The method needed to be rapid, simple, and suitable for clinical research. No prior work had evaluated the effects of biotinylation on RBC parameters. This uncertainty drove the investigation into PS exposure, electrolytes, and morphology. The researchers sought to confirm that labeling does not harm RBC quality.

RCC fractions were labeled with two biotinylation reagent concentrations in a closed system. Flow cytometry was used to assess labeling reproducibility and robustness. The stability of the biotin label on irradiated and non-irradiated RCCs was tested. Researchers measured PS exposure, Na, K, free hemoglobin, ATP, pH, and morphology. These parameters were evaluated before and after the labeling process. The method was designed to be rapid, taking less than two hours. All steps were performed in a sterile environment to prevent contamination. The study followed Good Practice Guidelines for blood product development.

RCCs were successfully labeled in a closed system with two reagent concentrations. Biotinylation did not affect RBC morphology or function. PS exposure and electrolyte levels remained stable after labeling. ATP and pH values were unchanged, indicating no metabolic disruption. Free hemoglobin levels stayed within normal ranges. The labeling method was rapid, taking less than two hours. Flow cytometry confirmed consistent and robust biotin labeling. The method met Good Practice Guidelines for blood product manufacturing.

The study demonstrated a sterile, rapid method for biotin labeling of RCCs. The procedure did not compromise RBC function or stability. Two reagent concentrations were both effective and reproducible. The method is suitable for clinical research and product evaluation. Researchers confirmed that labeling does not alter RBC parameters. The process complies with Good Practice Guidelines. This approach provides a reliable way to track donor RBCs. The findings support the use of this method in future transfusion studies.